Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications
Article in International Journal of Molecular Sciences (April 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Influence of Hemoglobin S Haplotypes on the Responses to Hydroxyurea Treatment in Children with Sickle Cell Disease in Abidjan, Côte d’Ivoire
Article in Open Journal of Genetics (March 2024)
Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management
Article in International Journal of Molecular Sciences (March 2024)